What this study is
The purpose of the study is to refine, finalize, implement, and evaluate a multi-level intervention aimed at increasing enrollment of Black and Hispanic patients to National Cancer Institute (NCI)-sponsored therapeutic clinic trials at Moffitt Cancer Center.
What's being tested
- Continuing Medical Education Events (CME)
Intervention · BEHAVIORAL
An engaging 1-hour informational session focusing on topic areas such as implicit bias and emerging evidence from recent cancer clinical trials with CME credit or American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points available.
- Trial Connect Portal
Intervention · BEHAVIORAL
A digital tool to help facilitate rapid referral of patients to clinical trial opportunities at Moffitt.
- Clinical Trial Newsletters
Intervention · BEHAVIORAL
Electronic/paper newsletters to highlight open trials at Moffitt that will be distributed by email/mail.
- Implicit Bias Training
Intervention · BEHAVIORAL
A one-hour educational module will cover information on implicit bias to support the recruitment of diverse patients.
- Recruitment Dashboard
Intervention · BEHAVIORAL
A dynamic dashboard depicting the number of patients recruited to clinical trials by gender, race, ethnicity, age, cancer type, residence in the catchment area, and other key clinical characteristics.
- Portfolio Profiler
Intervention · BEHAVIORAL
An interactive dashboard to allow cancer center physicians easily identify gaps in the current clinical trial portfolio that may be contributing to racial/ethnic disparities in trial enrollment.
- Eligibility Calculator
Intervention · BEHAVIORAL
A digital calculator that will allow for assessment of the potential impact of clinical trial eligibility criteria (e.g., comorbidities, age, lab values) that may disproportionately exclude patients who are Black and Hispanic prior to submission of clinical trial protocols to the Scientific Review Committee.
- Clinical Trial Education Sessions (Community Residents Only)
Intervention · BEHAVIORAL
An engaging 1-hour educational session delivered by a community health educator that includes basic information about clinical trials, their importance, myths, need for diversity in the trials process, and resources for finding more information about clinical trials.
- ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients)
Intervention · BEHAVIORAL
A study team member will be available for questions via a dedicated phone-line and email for community residents and Moffitt patients with a return contact within 24-hours.
- New Patient Information (Moffitt Patients Only)
Intervention · BEHAVIORAL
Including CHOICES DA, a web-based tool to improve multiple aspects of decision-making related to participation in cancer clinical trials.
- No Intervention
Intervention · OTHER
Control group with no intervention.
Study details
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Conditions
- Cancer
- Enrolling
- 7,649 people
- Starts
- 2024-09-18
- Est. completion
- 2026-09-16
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Community residents: Community residents may engage with various intervention components deployed in the intervention priority zones.
- Community Physicians: may engage with various intervention components deployed in the intervention priority zones if they 1) practice medicine in one of the geographic priority zones.
- Cancer Center Physicians: may engage with various intervention components if they 1) practice medicine at Moffitt.
- Clinical Research Coordinators (CRC): may engage with various intervention components if they 1) work as a CRC at Moffitt and 2) coordinate/pre-screen patients for at least 1 therapeutic clinical trial at Moffitt.
- Cancer Center Patients: may engage with various intervention components if they have an address that maps to an intervention priority zone and 2) are newly registered patients or new existing patients (NEPs).
You can't join if
- Community residents, Community Physicians, Cancer Center Physicians, Clinical Research Coordinators, and Moffitt patients who do not meet the inclusion criteria.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMoffitt Cancer Center
Tampa, Florida, United States
- Rossybelle Amorrortu, MPH · Contact813-745-4007Rossybelle.Amorrortu@moffitt.org
- Lindsay Fuzzell, PhD · ContactLinsday.Fuzzell@moffitt.org
- Susan Vadaparampil, PhD · Principal investigator
- Dana Rollison, PhD · Principal investigator
- Kea Turner, PhD · Sub-investigator
- Kedar Kirtane, MD · Sub-investigator
- Hatem Soliman, MD · Sub-investigator
- Margaret Byrne, PhD · Sub-investigator
- Cathy Meade, PhD · Sub-investigator
- Clement Gwede, PhD · Sub-investigator
- Steven Eschrich, PhD · Sub-investigator
- Vivien Yin, PhD · Sub-investigator
Recruiting
Study team
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID MCC-22140
Principal investigator
Susan Vadaparampil, PhD
Moffitt Cancer Center
Principal investigator
Dana Rollison, PhD
Moffitt Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.